COMPASS THERAPEUTICS, INC. Accumulated Other Comprehensive Income
COMPASS THERAPEUTICS, INC. (CMPX) had Accumulated Other Comprehensive Income of -$251.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$251.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$159.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $280.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $274.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$251.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$159.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $280.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $274.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $208.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $190.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $210.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $486.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$91.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$90.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $37.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | -$430.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$507.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$146.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$302.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | -$641.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$512.00K 10-Q · filed 2022-08-01 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |